Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Hutchison China Meditech Limited LSE:HCM London Ordinary Share KYG4672N1016 ORD USD1
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 4,025.00p 3,950.00p 4,100.00p 4,025.00p 4,025.00p 4,025.00p 556 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 167.9 -68.0 -88.6 - 2,677.94

Hutchison China Meditech Share Discussion Threads

Showing 1976 to 1996 of 2000 messages
Chat Pages: 80  79  78  77  76  75  74  73  72  71  70  69  Older
DateSubjectAuthorDiscuss
17/5/2019
10:22
Nerdofsteel 17 May '19 - 10:19 - 1924 of 1924 0 0 0 Astrazeneca released their ASCO2019 prsentation schedules yesterday, which includes Savolitinib Https://www.astrazeneca.com/media-centre/press-releases/2019/astrazeneca-continues-to-redefine-cancer-treatment-at-the-2019-asco-annual-meeting-16052019.html
ariane
17/5/2019
10:19
Astrazeneca released their ASCO2019 prsentation schedules yesterday, which includes Savolitinib hxxps://www.astrazeneca.com/media-centre/press-releases/2019/astrazeneca-continues-to-redefine-cancer-treatment-at-the-2019-asco-annual-meeting-16052019.html
nerdofsteel
16/5/2019
09:13
indeed, I lived in the United States for 3 years, my brother has dual citizenship and my sister-in-law is American
nerdofsteel
16/5/2019
07:37
MRF filtered
shaker44
15/5/2019
20:53
Been here before.Set to climb back to $30 hopefully.
steeplejack
15/5/2019
20:49
Excellent session at the DB ADR Virtual Investor Conference today www.adr.db.com/dbvic
nerdofsteel
15/5/2019
13:16
Nerdofsteel 15 May '19 - 07:10 - 1915 of 1915 0 1 0 The J P Morgan China Summit took place on the 8th May, and Chi-Med have uploaded the presented content to the website Https://www.chi-med.com/jpm-global-china-summit-2019/
maywillow
15/5/2019
07:10
The J P Morgan China Summit took place on the 8th May, and Chi-Med have uploaded the presented content to the website hxxps://www.chi-med.com/jpm-global-china-summit-2019/
nerdofsteel
15/5/2019
05:43
It's only got to gain 20% to reverse this weeks losses ;o-)
nerdofsteel
14/5/2019
17:31
Any doubt that HCM is not a China proxy removed today. Within 5 minutes of Trump saying trade talks were still alive the stock jumped. Totally unrelated to reality but that is the way it is.
dbadvn
14/5/2019
07:21
Nice Fool article https://www.fool.co.uk/investing/2019/05/13/this-aim-listed-20-bagger-is-the-best-stock-i-never-bought/
nerdofsteel
14/5/2019
07:15
The ironic thing is that Chinese drugs and other pharmaceutical products are exempt from import tariffs and that is planned to remain the case
nerdofsteel
14/5/2019
07:12
I bought a significant number of shares yesterday because the Co's fundamentals have not changed. For any medicines approved in the U.S. such as Savolitinib, it will be a first or best-in-class and I can't see how any tariffs applied would reduce the demand for the product. President Trump has just done me a favour.
nerdofsteel
13/5/2019
16:38
Down 24% in 4 weeks on USA market. Clearly not based on fundamentals. Looks a good buying opportunity
shaker44
13/5/2019
16:13
Buying again at this level. Steeplejack is correct this fall is related to China trade talks and nothing to do with the fundamentals. As long as the long term story is intact I will stay in. HK listing will effectively draw an end to the trade talk proxy in any case . Looks more and more like a shrewd move by management.
dbadvn
12/5/2019
15:57
ASCO abstracts including Savolitinib available this coming Wednesday
nerdofsteel
12/5/2019
08:58
For those very reasons I've switched to buying ADR's only now.
nerdofsteel
11/5/2019
17:59
GW Pharmaceuticals closed their AIM listing because they considered the Nasdaq a more educated market as far as biotech was concerned and thus a better market on which to raise finance.This was despite GWP being a U.K. domiciled company with a very British history. It’s possible that HCM might step up to a full UK listing but I reckon that the same considerations that applied to GWPs thinking are relevant to HCM.Its more than likely that HCM will,in time,delist from AIM.There’s little traded volume and actually a lot of UK funds don’t invest in AIM stocks being outside of their defined remit.AIM is a pitifully unregulated market with only a few serious long term players who are conspicuous by their success.Frankly,AIM is not a listing for a top notch company like HCM.Should they really be sharing the same arena that has played host to companies like Quindell . If HCM did delist,then it will be problem for PIs.You’d be offered stock in HK or the US but it’s all very fiddly and some brokers simply don’t facilitate the transfer.Nine times out of ten,you’ll end up selling to avoid complications and buying the stock afresh ,on Nasdaq or in Hong Kong,if so inclined.
steeplejack
11/5/2019
17:54
sportii, whilst there is a dircet link between the number of AIM Ordinary shares and ADR's on NASDAQ (dhortly to become 5 Ordinary shares = 1 ADR) I don't believe there will be any such link to HK listed shares as there is no mechanism to run a joint book between the two. So my understanding is this will be a separate standalone listing, however I would expect all 3 markets to value the Company in equilibrium.
nerdofsteel
11/5/2019
16:19
Nofs, thanks for the information. Regarding forthcoming HKSE listing; will the new shares to be listed on HKSE going to be ‘interlinked’ with AIM and NYSE listed shares? Hope it will work out well for the company with a vastly increased investor numbers over a much wider geographical area.
sportii
11/5/2019
08:32
Sportii, I have previously asked a question at 2 AGM's about the London listing and the Board have been clear they will maintain it for the forseeable future, however that was prior to the HK listing announcement. I suspect it will remain for now, but in the long term I can see little point in maintaining it for the reasons I stated.
nerdofsteel
Chat Pages: 80  79  78  77  76  75  74  73  72  71  70  69  Older
Your Recent History
LSE
HCM
Hutchison ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190519 09:21:47